HOME >> BIOLOGY >> NEWS
MIT particles pave way for new bedside diagnostics

CAMBRIDGE, Mass.--MIT researchers have created an inexpensive method to screen for millions of different biomolecules (DNA, proteins, etc.) in a single sample-a technology that could make possible the development of low-cost clinical bedside diagnostics.

The work, based on tiny customizable particles, could also be used for disease monitoring, drug discovery or genetic profiling. Even though the particles are thinner than the width of a human hair, each is equipped with a barcoded ID and one or more probe regions that turn fluorescent when they detect specific targets in a test sample.

Using a new, extremely versatile technique, the researchers can produce a "virtually unlimited" array of particles to test for DNA, RNA, proteins and other biomolecules, said Daniel Pregibon, a graduate student in chemical engineering at MIT.

Pregibon is the lead author of a paper on the work that will appear in the March 9 issue of Science.

He and co-author Patrick Doyle, the Doherty Associate Professor of Chemical Engineering, believe their particles could become an effective and inexpensive way to perform medical diagnostic tests at a patient's bedside.

Current testing methods are cost-prohibitive for bedside use, Pregibon said. The MIT particles are inexpensive to manufacture, and their results are as accurate, if not more so, than the results from more expensive systems, he said.

The particles offer a new way to do "multiplexed detection"-testing a single sample for multiple targets. In the laboratory, a common (but expensive) multiplexing technique involves a planar microarray-a flat surface with many spotted probes that each test for different targets. The MIT researchers are taking this approach away from planar surfaces onto free-floating particles.

With the tiny particles, it is much easier to custom-design each biological test, said Doyle. "It's very easy to tailor what you give a customer. You could
'"/>

Contact: Elizabeth Thomson
thomson@mit.edu
617-258-5402
Massachusetts Institute of Technology
8-Mar-2007


Page: 1 2 3

Related biology news :

1. Gold nanoparticles may pan out as tool for cancer diagnosis
2. Under magnetic force, nanoparticles may deliver gene therapy
3. UCSB researchers show how to make polymeric micro- and nanoparticles
4. Soil particles found to boost prions capacity to infect
5. Nanoparticles hitchhike on red blood cells: a potential new method for drug delivery
6. Pairing nanoparticles with proteins
7. Nanoparticles carry chemotherapy drug deeper into solid tumors
8. In nature, proteins sweep up nanoparticles
9. Bacteria ferry nanoparticles into cells for early diagnosis, treatment
10. MU researchers examine the environmental effects of silver nanoparticles
11. Work with nanoparticles may lead to on-the-spot virus detector

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2020)... (PRWEB) , ... April 23, 2020 , ... ... specializing in computer miniaturization, backed by FII Tech Growth managed by Fondo Italiano ... in the biomedical market, for the development of Respira, a new non-invasive pulmonary ...
(Date:4/23/2020)... ... 23, 2020 , ... Despite the current COVID-19 environment, MDG ... for the animal feed, human consumption, wastewater, and biotech sectors, and demand for ... from overseas competitors have become weakened or shut down completely, new inquiries come ...
(Date:4/22/2020)... ... April 21, 2020 , ... Captis ... venture capital firm that provides patent development support for early stage startups. The ... illnesses such as ovarian cancer and precancerous pancreatic lesions with simple, accurate and ...
Breaking Biology News(10 mins):
(Date:4/26/2020)... ... April 23, 2020 , ... Indegene Omnipresence, Inc. announced ... applications and services for use on Microsoft Azure. The customer experience management (CXM) ... online for a built-for-purpose customer engagement capability to use in their commercial or ...
(Date:4/22/2020)... ... April 20, 2020 , ... ... MA, announced today that Omixon’s founder and chairman Dr. Attila Berces returns as ... product Holotype HLA since 2014 before stepping into the CEO role in 2017. ...
(Date:4/22/2020)... ... April 21, 2020 , ... Ripple Science today announced ... trial teams are working remotely and have paused patient visits, forcing teams to ... their research during this uncertain time by giving research teams free access to ...
(Date:4/7/2020)... ... April 06, 2020 , ... Gateway Genomics , ... reached 200,000 SneakPeek Early Gender DNA Tests sold in March, just months ... launched as an ecommerce product, where a mom could order her kit online, collect ...
Breaking Biology Technology:
Cached News: